Conference Coverage (NCVDG)

UBI Testing HIV Vaccine in Brazil

Published in Blood Weekly, March 11th, 1996

Brazil is currently conducting a Phase I/II clinical trial of an experimental HIV vaccine manufactured by United Biomedical Inc., Hauppauge, New York.

Enrollment began in February 1995 at two centers: Minas Gerais and Rio de Janeiro.

Each center is following 15 volunteers and three additional subjects who will receive a placebo in the blinded study. All volunteers are at low risk of HIV infection.

The trial is intended to evaluate different dose and vaccination schedules. Details of the trial were announced at the Eighth Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS (NCVDG), held February 11-15,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1996-03-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry